Moderna’s new influenza vaccine, based on the same mRNA technology used in its COVID-19 vaccine, showed promising results in a major trial.

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

The Serum Institute of India, manufacturer of Covishield, on Thursday reaffirmed the safety of Covid-19 vaccines amid rising ...

In a social media post, Siddaramaiah said that the "hasty approval and distribution" of the Covid vaccine could be a reason for recent heart attack deaths in Hassan, Karnataka.